What is MaxCyte's debt-to-equity?

MaxCyte (MXCT) reported debt-to-equity of 0.1× in Q1 2026.

How has MaxCyte's debt-to-equity changed year-over-year?

MaxCyte's debt-to-equity increased by 10.4% year-over-year, from 0.1× to 0.1×.

What is the long-term trend for MaxCyte's debt-to-equity?

Over 5 years (2020 to 2025), MaxCyte's debt-to-equity has grown at a -13.0% compound annual growth rate (CAGR), from 0.2× to 0.1×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

MaxCyte MXCT Debt-to-equity

Debt-to-equity at other companies

Bio-Rad LaboratoriesBIO

0.1×-0.1×

Thermo Fisher ScientificTMO

0.8×+0.1×

Ginkgo BioworksDNA

0.9×+0.3×

Immix Biopharma, Inc.IMMX

0×-0.1×

Rapid Micro BiosystemsRPID

1.2×+1.1×

PDE

Pro-Dex, Inc.PDEX

0.4×0.0×

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

total debt/total stockholders equity=0.1×

Based on the most recent quarter.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's debt-to-equity?: MaxCyte (MXCT) reported debt-to-equity of 0.1× in Q1 2026.
How has MaxCyte's debt-to-equity changed year-over-year?: MaxCyte's debt-to-equity increased by 10.4% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for MaxCyte's debt-to-equity?: Over 5 years (2020 to 2025), MaxCyte's debt-to-equity has grown at a -13.0% compound annual growth rate (CAGR), from 0.2× to 0.1×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.